| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.07 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |